Enhanced quality of hESC-derived melanocytes through modified concentration of endothelin-1

Exp Dermatol. 2024 Jan;33(1):e15004. doi: 10.1111/exd.15004.

Abstract

The study investigated the effectiveness of EDN1 and EDN3 cytokines in the differentiation of melanocytes from hESCs. The findings showed that 100 nM EDN1 was more effective in promoting hESC to CD117+/TYR+ melanoblasts compared to 100 nM EDN3. Additionally, maintaining melanoblasts is beneficial for preserving the ability to proliferate. The study found that 10 nM EDN1 helped maintain the proliferation of melanoblasts without over maturing them into melanocytes in the late stage of differentiation. Thus, using 100 nM EDN1 in the initial stage and 10 nM EDN1 in the late stage proved to be an efficient and cost-effective method for obtaining hESC-derived melanocytes. The preliminary results suggest that EDN1 promotes melanoblast formation during the initial differentiation stage through its binding to both the EDNRB receptor and EDNRA receptor. This study provides a valuable tool for studying the development of human melanocytes and modelling the biology of disease.

Keywords: differentiation; endothelin; endothelin receptor; human embryonic stem cells; melanocytes.

MeSH terms

  • Cell Differentiation
  • Endothelin-1* / metabolism
  • Human Embryonic Stem Cells*
  • Humans
  • Melanocytes / metabolism

Substances

  • Endothelin-1